Charles Antzelevitch

Charles Antzelevitch's AcademicInfluence.com Rankings

Medical

#424

World Rank

#585

Historical Rank

#176

USA Rank

Cardiology

#29

World Rank

#29

Historical Rank

USA Rank

medical Degrees

Charles Antzelevitch

Physics

#2391

World Rank

#3545

Historical Rank

#951

USA Rank

Biophysics

#51

World Rank

#55

Historical Rank

#19

USA Rank

physics Degrees

Download Badge

Medical
Physics

Charles Antzelevitch's Degrees

PhD Biophysics University of Pennsylvania
Masters Biophysics University of Pennsylvania
Bachelors Physics City College of New York

Why Is Charles Antzelevitch Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Charles Antzelevitch is an American cardiovascular research scientist in the fields of cardiac electrophysiology and cardiac arrhythmia syndromes. Education Antzelevitch graduated from Queens College, City University of New York with a BA in biology. He earned a PhD in pharmacology from State University of New York Upstate Medical University in 1978. From 1977 to 1980, he held a postdoctoral fellowship in the department of experimental cardiology at the Masonic Medical Research Laboratory in Utica, New York.

(See a Problem?)

Charles Antzelevitch's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd (2006) (2840)
Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. (2005) (1762)
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation (1998) (1747)
Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. (1999) (1085)
Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death (2007) (901)
Brugada syndrome: report of the second consensus conference. (2005) (838)
Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG (2003) (817)
Proposed diagnostic criteria for the Brugada syndrome: consensus report. (2002) (803)
Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. (1991) (774)
Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. (1998) (766)
Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. (2000) (762)
Cellular basis for the electrocardiographic J wave. (1996) (753)
Brugada syndrome. (2006) (741)
Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties (2004) (659)
Characteristics of the delayed rectifier current (IKr and IKs) in canine ventricular epicardial, midmyocardial, and endocardial myocytes. A weaker IKs contributes to the longer action potential of the M cell. (1995) (644)
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. (2010) (641)
Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. (1999) (615)
Long-Term Follow-Up of Individuals With the Electrocardiographic Pattern of Right Bundle-Branch Block and ST-Segment Elevation in Precordial Leads V1 to V3 (2002) (608)
The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. (2000) (543)
J wave syndromes. (2010) (527)
A subpopulation of cells with unique electrophysiological properties in the deep subepicardium of the canine ventricle. The M cell. (1991) (521)
The Brugada syndrome: clinical, electrophysiologic and genetic aspects. (1999) (505)
Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes. (1994) (504)
Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes. (1998) (484)
Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. (1993) (483)
Transient Outward Current Prominent in Canine Ventricular Epicardium but Not Endocardium (1988) (466)
Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome. (2006) (449)
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death (2013) (441)
The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. (2000) (408)
The Brugada Syndrome: Ionic Basis and Arrhythmia Mechanisms (2001) (406)
Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations. (1998) (396)
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. (2010) (396)
Proposed diagnostic criteria for the Brugada syndrome. (2002) (395)
Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. (2002) (394)
Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. (1997) (388)
Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. (2000) (382)
J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. (2016) (374)
Ionic and Cellular Basis for the Predominance of the Brugada Syndrome Phenotype in Males (2002) (371)
Effect of Epicardial or Biventricular Pacing to Prolong QT Interval and Increase Transmural Dispersion of Repolarization: Does Resynchronization Therapy Pose a Risk for Patients Predisposed to Long QT or Torsade de Pointes? (2003) (369)
A molecular link between the sudden infant death syndrome and the long-QT syndrome. (2000) (364)
Early repolarization syndrome: clinical characteristics and possible cellular and ionic mechanisms. (2000) (340)
Functional Effects of KCNE3 Mutation and Its Role in the Development of Brugada Syndrome (2008) (335)
Drug‐Induced Torsades de Pointes and Implications for Drug Development (2004) (330)
Short QT syndrome: pharmacological treatment. (2004) (324)
Electrical heterogeneity within the ventricular wall (2001) (321)
The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization. (2010) (317)
Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation: Differences in Sodium Channel Inactivation Between Atria and Ventricles and the Role of Ranolazine (2007) (316)
Cellular and ionic basis for T-wave alternans under long-QT conditions. (1999) (314)
Unique Topographical Distribution of M Cells Underlies Reentrant Mechanism of Torsade de Pointes in the Long-QT Syndrome (2002) (312)
Contemporary Definitions and Classification of the Cardiomyopathies (2006) (303)
Reinduction of Atrial Fibrillation Immediately After Termination of the Arrhythmia Is Mediated by Late Phase 3 Early Afterdepolarization–Induced Triggered Activity (2003) (300)
The Early Repolarization Pattern: A Consensus Paper. (2015) (296)
Assessing predictors of drug-induced torsade de pointes. (2003) (295)
Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes. (1996) (285)
Differences in the Electrophysiological Response of Canine Ventricular Epicardium and Endocardium to Ischemia Role of the Transient Outward Current (1993) (281)
I(to) and action potential notch are smaller in left vs. right canine ventricular epicardium. (1996) (276)
Does Tpeak-Tend provide an index of transmural dispersion of repolarization? (2007) (275)
Augmentation of J waves and electrical storms in patients with early repolarization. (2008) (274)
Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. (2001) (263)
A Mutation in the β3 Subunit of the Cardiac Sodium Channel Associated With Brugada ECG Phenotype (2009) (262)
Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium. (1990) (262)
Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. (2007) (261)
Overview of Basic Mechanisms of Cardiac Arrhythmia. (2011) (244)
The Homeodomain Transcription Factor Irx5 Establishes the Mouse Cardiac Ventricular Repolarization Gradient (2005) (244)
Cellular basis for QT dispersion. (1998) (243)
Flecainide‐Induced Arrhythmia in Canine Ventricular Epicardium Phase 2 Reentry? (1993) (242)
Effect of Sodium Channel Blockers on ST Segment, QRS Duration, and Corrected QT Interval in Patients with Brugada Syndrome (2000) (238)
Epicardial Activation of Left Ventricular Wall Prolongs QT Interval and Transmural Dispersion of Repolarization: Implications for Biventricular Pacing (2004) (229)
Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. (2011) (229)
Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. (2014) (222)
Transmural heterogeneity of calcium activity and mechanical function in the canine left ventricle. (2004) (211)
Brugada syndrome: a decade of progress. (2002) (211)
Autonomic aspects of arrhythmogenesis: the enduring and the new (2004) (210)
Electrophysiologic basis for the antiarrhythmic actions of ranolazine. (2011) (208)
Phase 2 reentry as a mechanism of initiation of circus movement reentry in canine epicardium exposed to simulated ischemia. (1996) (208)
Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium. (1989) (203)
The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. (2010) (203)
Brugada syndrome: 1992-2002: a historical perspective. (2003) (192)
Characteristics of Reflection as a Mechanism of Reentrant Arrhythmias and Its Relationship to Parasystole (1980) (191)
Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis (2015) (190)
Cellular mechanisms underlying the long QT syndrome. (2002) (189)
Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes. (2005) (189)
Antiarrhythmic Effects of Ranolazine in a Guinea Pig in Vitro Model of Long-QT Syndrome (2004) (186)
Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. (2000) (185)
Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome. (2010) (185)
Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. (2005) (182)
Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6). (2011) (181)
Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes. (2007) (181)
Phase resetting and annihilation of pacemaker activity in cardiac tissue. (1979) (180)
Further Insights into the Effect of Quinidine in Short QT Syndrome Caused by a Mutation in HERG (2005) (178)
Tpeak–Tend interval as an index of transmural dispersion of repolarization (2001) (175)
Amplified Transmural Dispersion of Repolarization as the Basis for Arrhythmogenesis in a Canine Ventricular-Wedge Model of Short-QT Syndrome (2004) (172)
I(NaCa) contributes to electrical heterogeneity within the canine ventricle. (2000) (169)
Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. (1991) (168)
Rate dependence of action potential duration and refractoriness in canine ventricular endocardium differs from that of epicardium: role of the transient outward current. (1989) (167)
Value of Electrocardiographic Parameters and Ajmaline Test in the Diagnosis of Brugada Syndrome Caused by SCN5A Mutations (2004) (162)
Role of sodium and calcium channel block in unmasking the Brugada syndrome. (2004) (162)
Genetic, molecular and cellular mechanisms underlying the J wave syndromes. (2012) (161)
Heterogeneity and cardiac arrhythmias: an overview. (2007) (161)
Transmural Heterogeneity of Ventricular Repolarization Under Baseline and Long QT Conditions in the Canine Heart In Vivo: Torsades de Pointes Develops with Halothane but not Pentobarbital Anesthesia (2000) (160)
J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge☆☆☆ (2016) (156)
Molecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8. (2012) (153)
Chronic Amiodarone Reduces Transmural Dispersion of Repolarization in the Canine Heart (1997) (150)
Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry? (1993) (148)
Electrocardiographic changes predicting sudden death in propofol-related infusion syndrome. (2006) (147)
Maximum Diastolic Potential of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Depends Critically on IKr (2012) (147)
Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes (2006) (143)
Short QT Syndrome: From Bench to Bedside (2010) (141)
Potential proarrhythmic effects of biventricular pacing. (2005) (139)
Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome. (1999) (139)
Cellular mechanisms underlying the long QT syndrome. (2003) (139)
Distribution of M Cells in the Canine Ventricle (1994) (136)
Sodium Pentobarbital Reduces Transmural Dispersion of Repolarization and Prevents Torsades de Pointes in Models of Acquired and Congenital Long QT Syndrome (1999) (135)
Fever-induced Brugada pattern: how common is it and what does it mean? (2013) (135)
Gain of function in IKs secondary to a mutation in KCNE5 associated with atrial fibrillation. (2008) (132)
Cellular Basis for Complex T Waves and Arrhythmic Activity Following Combined IKr and IKs Block (2001) (131)
The role of late I Na in development of cardiac arrhythmias. (2014) (128)
Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent (2004) (125)
Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias. (2006) (124)
Acceleration‐Induced Action Potential Prolongation and Early Afterdepolarizations (1998) (124)
Brugada syndrome: from cell to bedside. (2001) (122)
Cisapride-Induced Transmural Dispersion of Repolarization and Torsade de Pointes in the Canine Left Ventricular Wedge Preparation During Epicardial Stimulation (2003) (120)
Late‐Phase 3 EAD. A Unique Mechanism Contributing to Initiation of Atrial Fibrillation (2006) (120)
Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome. (2009) (120)
Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations. (2008) (119)
Evidence for the Presence of M Cells in the Guinea Pig Ventricle (1996) (117)
J-wave syndromes: Brugada and early repolarization syndromes. (2015) (114)
The arrhythmogenic consequences of increasing late INa in the cardiomyocyte. (2013) (113)
Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome. (1999) (113)
Transmural dispersion of repolarization and the T wave. (2001) (112)
Atrial fibrillation and Brugada syndrome. (2008) (112)
Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome. (2014) (112)
Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry. (2009) (112)
A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome. (2008) (111)
Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome. (2014) (111)
J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. (2016) (111)
High [Ca2+]o-induced electrical heterogeneity and extrasystolic activity in isolated canine ventricular epicardium. Phase 2 reentry. (1994) (110)
Ischemic ventricular arrhythmias: experimental models and their clinical relevance. (2011) (110)
ABCC9 is a novel Brugada and early repolarization syndrome susceptibility gene. (2014) (110)
Arrhythmogenic mechanisms of QT prolonging drugs: is QT prolongation really the problem? (2004) (106)
Drug‐Induced Afterdepolarizations and Triggered Activity Occur in a Discrete Subpopulation of Ventricular Muscle Cells (M Cells) in the Canine Heart: (1993) (106)
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. (2012) (105)
The Brugada Syndrome: Is an Implantable Cardioverter Defibrillator the Only Therapeutic Option? (2002) (103)
Electrophysiologic Characteristics of M Cells in the Canine Left Ventricular Free Wall (1995) (101)
Electrotonically Mediated Delayed Conduction and Reentry in Relation to “Slow Responses” in Mammalian Ventricular Conducting Tissue (1981) (101)
Long-Term Follow-Up of Individuals With the Electrocardiographic Pattern of Right Bundle-Branch Block and ST-Segment Elevation in Precordial Leads V 1 to V 3 (2001) (101)
Compound Heterozygous Mutations P336L and I1660V in the Human Cardiac Sodium Channel Associated With the Brugada Syndrome (2006) (100)
Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation. (2010) (97)
The Brugada Syndrome: From Bench to Bedside (2005) (96)
Drug-induced spatial dispersion of repolarization. (2008) (96)
Inhibition of late (sustained/persistent) sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and its detrimental effects on cardiomyocyte function (2004) (95)
Dimethyl Lithospermate B, an Extract of Danshen, Suppresses Arrhythmogenesis Associated With the Brugada Syndrome (2006) (93)
Ion channels and ventricular arrhythmias: cellular and ionic mechanisms underlying the Brugada syndrome. (1999) (93)
Risk stratification in Brugada syndrome: Clinical characteristics, electrocardiographic parameters, and auxiliary testing. (2016) (92)
Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine. (2007) (91)
HMR 1556, A Potent and Selective Blocker of Slowly Activating Delayed Rectifier Potassium Current (2003) (90)
Induced pluripotent stem cells as a model for accelerated patient- and disease-specific drug discovery. (2010) (90)
Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7). (2006) (89)
Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome. (2008) (88)
The Role of Sodium Channel Current in Modulating Transmural Dispersion of Repolarization and Arrhythmogenesis (2006) (87)
High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia. (2015) (85)
Fever and Brugada Syndrome (2002) (85)
Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine. (2008) (85)
Cellular Basis of the T Wave: A Century of Controversy (2009) (85)
Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects. (2016) (84)
Inherited cardiac arrhythmias (2020) (83)
Long QT, syndactyly, joint contractures, stroke and novel CACNA1C mutation: Expanding the spectrum of Timothy syndrome (2012) (82)
Cellular Basis for the Repolarization Waves of the ECG (2006) (82)
Synergistic Electrophysiologic and Antiarrhythmic Effects of the Combination of Ranolazine and Chronic Amiodarone in Canine Atria (2010) (81)
Electromechanical coupling in patients with the short QT syndrome: further insights into the mechanoelectrical hypothesis of the U wave. (2008) (80)
Short QT syndrome. Genotype-phenotype correlations. (2005) (79)
Basic mechanisms of reentrant arrhythmias. (2001) (79)
Antiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967. (2013) (79)
The Case for Modulated Parasystole (1982) (79)
Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome. (2005) (78)
Late potentials and the Brugada syndrome. (2002) (78)
Afterdepolarizations and Triggered Activity Develop in a Select Population of Cells (M Cells) in Canine Ventricular Myocardium: The Effects of Acetylstrophanthidin and Bay K 8644 (1991) (78)
Parasystole, reentry, and tachycardia: a canine preparation of cardiac arrhythmias occurring across inexcitable segments of tissue. (1983) (77)
J wave syndromes: molecular and cellular mechanisms. (2013) (77)
Cardiac repolarization. The long and short of it. (2005) (76)
Electrotonic Modulation of Pacemaker Activity Further Biological and Mathematical Observations on the Behavior of Modulated Parasystole (1982) (76)
Cellular Mechanisms Underlying the Development of Catecholaminergic Ventricular Tachycardia (2005) (76)
The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome. (2012) (75)
Divergent expression of delayed rectifier K(+) channel subunits during mouse heart development. (2001) (74)
The Brugada syndrome: clinical, genetic, cellular, and molecular abnormalities. (2001) (74)
Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone. (2008) (74)
Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation. (2009) (74)
Effects of Sodium Channel Block with Mexiletine to Reverse Action Potential Prolongation in In Vitro Models of the Long QT Syndrome (1997) (73)
A Novel Mutation in the HCN4 Gene Causes Symptomatic Sinus Bradycardia in Moroccan Jews (2010) (73)
Cellular basis and mechanism underlying normal and abnormal myocardial repolarization and arrhythmogenesis (2004) (73)
Novel mutation in the SCN5A gene associated with arrhythmic storm development during acute myocardial infarction. (2007) (72)
Novel mutations in the KCND3‐encoded Kv4.3 K+ channel associated with autopsy‐negative sudden unexplained death (2012) (71)
Novel Timothy syndrome mutation leading to increase in CACNA1C window current. (2015) (70)
Transmembrane action potential heterogeneity in the canine isolated arterially perfused right atrium: effect of IKr and IKur/Ito block. (2004) (70)
Atrial‐Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation (2008) (70)
Phenotypical Manifestations of Mutations in the Genes Encoding Subunits of the Cardiac Voltage–Dependent L-Type Calcium Channel (2011) (69)
Rationale for the use of the terms J-wave syndromes and early repolarization. (2011) (69)
Electrotonic inhibition and summation of impulse conduction in mammalian Purkinje fibers. (1983) (69)
In vivo human demonstration of phase 2 reentry. (2005) (68)
Block of IKs Does Not Induce Early Afterdepolarization Activity but Promotes β‐Adrenergic Agonist‐Induced Delayed Afterdepolarization Activity (2000) (68)
Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation. (2008) (68)
Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation. (2012) (67)
Electrophysiological Mechanisms Underlying Rate‐Dependent Changes of Refractoriness in Normal and Segmentally Depressed Canine Purkinje Fibers: The Characteristics of Post‐Repolarization Refractoriness (1986) (66)
Quinidine: a valuable medication joins the list of 'endangered species'. (2007) (65)
Prognostic significance of fever-induced Brugada syndrome. (2016) (65)
Sudden cardiac death secondary to antidepressant and antipsychotic drugs (2008) (65)
Cellular Mechanism Underlying Hypothermia-Induced Ventricular Tachycardia/Ventricular Fibrillation in the Setting of Early Repolarization and the Protective Effect of Quinidine, Cilostazol, and Milrinone (2014) (64)
Cellular basis for ST-segment changes observed during ischemia. (2003) (64)
Novel mutations in domain I of SCN5A cause Brugada syndrome. (2002) (63)
Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): Standardised Reporting for Model Reproducibility, Interoperability, and Data Sharing (2011) (63)
Electrical heterogeneity, cardiac arrhythmias, and the sodium channel. (2000) (62)
Cellular and ionic basis for the sex-related difference in the manifestation of the Brugada syndrome and progressive conduction disease phenotypes. (2003) (61)
Prominent IKs in Epicardium and Endocardium Contributes to Development of Transmural Dispersion of Repolarization but Protects Against Development of Early Afterdepolarizations (2002) (60)
Cellular and ionic mechanisms responsible for the Brugada syndrome. (2000) (59)
New developments in atrial antiarrhythmic drug therapy (2010) (59)
Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: I. Experimental analysis of the use-dependent block. (2011) (59)
Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children. (2001) (59)
Cellular and subcellular alternans in the canine left ventricle. (2007) (58)
Phenotypic Characterization of a Large European Family with Brugada Syndrome Displaying a Sudden Unexpected Death Syndrome Mutation in SCN5A: (2004) (58)
Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome. (2006) (58)
A Common Single Nucleotide Polymorphism Can Exacerbate Long-QT Type 2 Syndrome Leading to Sudden Infant Death (2010) (58)
Coordinated down-regulation of KCNQ1 and KCNE1 expression contributes to reduction of I(Ks) in canine hypertrophied hearts. (2003) (57)
Identification and characterization of a transient outward K+ current in human induced pluripotent stem cell-derived cardiomyocytes. (2013) (57)
M cells in the human heart. (2010) (56)
Lidocaine-Induced Brugada Syndrome Phenotype Linked to a Novel Double Mutation in the Cardiac Sodium Channel (2005) (56)
Chromanol 293B Inhibits Slowly Activating Delayed Rectifier and Transient Outward Currents in Canine Left Ventricular Myocytes (2001) (56)
Modulation of Transmural Repolarization (2005) (56)
ECG phenomenon of idiopathic and paradoxical short QT intervals. (2002) (56)
Brugada syndrome: Recent advances and controversies (2008) (56)
Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome (2020) (55)
Brugada-Like Syndrome in Infancy Presenting With Rapid Ventricular Tachycardia and Intraventricular Conduction Delay (2012) (55)
Can inhibition of IKur promote atrial fibrillation? (2008) (55)
Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome. (2013) (54)
Genetic basis of Brugada syndrome. (2007) (54)
Atrial-Selective Sodium Channel Blockers: Do They Exist? (2008) (54)
Heterogeneity of cellular repolarization in LQTS: the role of M cells (2001) (53)
Brugada syndrome and ischemia-induced ST-segment elevation. Similarities and differences. (2005) (53)
Therapy for the Brugada syndrome. (2006) (53)
Differential effects of the transient outward K(+) current activator NS5806 in the canine left ventricle. (2009) (53)
Role of Late Sodium Channel Current Block in the Management of Atrial Fibrillation (2013) (52)
Rate-Dependent Effects of Vernakalant in the Isolated Non-Remodeled Canine Left Atria Are Primarily Due to Block of the Sodium Channel: Comparison With Ranolazine and dl-Sotalol (2012) (52)
Role of M cells in acquired long QT syndrome, U waves, and torsade de pointes. (1995) (52)
Ionic and Cellular Mechanisms Underlying the Development of Acquired Brugada Syndrome in Patients Treated with Antidepressants (2012) (51)
J-wave syndromes. from cell to bedside. (2011) (50)
Functionally distinct sodium channels in ventricular epicardial and endocardial cells contribute to a greater sensitivity of the epicardium to electrical depression. (2008) (50)
Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect (2016) (50)
The Brugada syndrome: diagnostic criteria and cellular mechanisms. (2001) (50)
Pacemaker annihilation: diagnostic and therapeutic implications. (1980) (50)
Cellular basis for the monophasic action potential. Which electrode is the recording electrode? (2002) (49)
Cellular Mechanism and Arrhythmogenic Potential of T‐Wave Alternans in the Brugada Syndrome (2008) (49)
Molecular Genetics of Arrhythmias and Cardiovascular Conditions Associated with Arrhythmias (2003) (49)
Role of K+ channel activators in cardiac electrophysiology and arrhythmias. (1992) (48)
Electrical Heterogeneity in the Heart: Physiological, Pharmacological and Clinical Implications (2011) (48)
Electrical diseases of the heart. Genetics, mechanisms, treatment, prevention. (2008) (48)
Synergistic Effect of the Combination of Dronedarone and Ranolazine to Suppress Atrial Fibrillation (2010) (47)
Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome. (2006) (47)
Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome. (2013) (47)
Rate‐dependent Changes in Excitability of Depressed Cardiac Purkinje Fibers as a Mechanism of Intermittent Bundle Branch Block (1983) (46)
Shanghai Score System for Diagnosis of Brugada Syndrome: Validation of the Score System and System and Reclassification of the Patients. (2018) (46)
Drug-induced QT-interval shortening following antiepileptic treatment with oral rufinamide. (2012) (46)
Acute myocardial ischemia: cellular mechanisms underlying ST segment elevation. (2014) (46)
Fever Accentuates Transmural Dispersion of Repolarization and Facilitates Development of Early Afterdepolarizations and Torsade de Pointes Under Long-QT Conditions (2008) (46)
Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data (2016) (45)
Torsades de pointes following acute myocardial infarction: evidence for a deadly link with a common genetic variant. (2012) (44)
Calcium Channel Mutations in Cardiac Arrhythmia Syndromes. (2015) (44)
The Brugada Numbers (reply to letter) (2003) (44)
Transseptal Dispersion of Repolarization and Its Role in the Development of Torsade de Pointes Arrhythmias (2010) (43)
Optical and electrical recordings from isolated coronary-perfused ventricular wedge preparations. (2013) (43)
Sympathetic modulation of the long QT syndrome. (2002) (43)
Functional expression of "cardiac-type" Nav1.5 sodium channel in canine intracardiac ganglia. (2006) (42)
Phase resetting and annihilation in a mathematical model of sinus node. (1985) (41)
Atrial-selective sodium channel block for the treatment of atrial fibrillation (2009) (41)
American Heart Association Atrial Fibrillation Research Summit: A Conference Report From the American Heart Association (2011) (41)
Pharmacological approach to the treatment of long and short QT syndromes. (2008) (40)
Ranolazine Effectively Suppresses Atrial Fibrillation in the Setting of Heart Failure (2014) (40)
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls (2020) (39)
A CACNA1C Variant Associated with Reduced Voltage-Dependent Inactivation, Increased CaV1.2 Channel Window Current, and Arrhythmogenesis (2014) (39)
Sudden cardiac death secondary to antidepressant and antipsychotic drugs. (2008) (39)
Link Between Hypothermia and the Brugada Syndrome (2004) (38)
Atrial-Selective Sodium Channel Block Strategy to Suppress Atrial Fibrillation: Ranolazine versus Propafenone (2012) (38)
Comparison of the Effects of a Transient Outward Potassium Channel Activator on Currents Recorded from Atrial and Ventricular Cardiomyocytes (2011) (38)
Physiological consequences of transient outward K+ current activation during heart failure in the canine left ventricle. (2012) (38)
Dual Variation in SCN5A and CACNB2b Underlies the Development of Cardiac Conduction Disease without Brugada Syndrome (2010) (38)
The M Cell (1997) (37)
Brugada syndrome: historical perspectives and observations. (2002) (37)
Influence of transmural repolarization gradients on the electrophysiology and pharmacology of ventricular myocardium. Cellular basis for the Brugada and long–QT syndromes (2001) (37)
Unraveling the Enigma of Bangungut: Is Sudden Unexplained Nocturnal Death Syndrome (SUNDS) in the Philippines a Disease Allelic to the Brugada Syndrome? (2011) (37)
Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: II. Insights from a mathematical model. (2011) (35)
The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome. (2017) (35)
Biophysical and Molecular Characterization of a Novel De Novo KCNJ2 Mutation Associated With Andersen-Tawil Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia Mimicry (2011) (34)
Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome. (2017) (34)
Extracellular proton depression of peak and late Na⁺ current in the canine left ventricle. (2011) (34)
Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations. (2011) (33)
The cardiologists' worst nightmare sudden death from "benign" ventricular arrhythmias. (2005) (33)
Usefulness of exercise test in the diagnosis of short QT syndrome. (2015) (31)
Differences in the electrophysiologic response of four canine ventricular cell types to alpha 1-adrenergic agonists. (1999) (31)
Molecular mechanisms underlying the long QT syndrome. (2002) (31)
Novel pharmacological targets for the rhythm control management of atrial fibrillation. (2011) (31)
KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders. (2010) (30)
Is there an overlap between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia? (2005) (30)
Modulation of canine cardiac sodium current by Apelin. (2010) (29)
A Novel Mutation in KCNQ1 Associated with a Potent Dominant Negative Effect as the Basis for the LQT1 Form of the Long QT Syndrome (2007) (29)
Cardiac Arrhythmias Related to Sodium Channel Dysfunction. (2018) (29)
Management of Ventricular Arrhythmias in Suspected Channelopathies (2015) (29)
Brugada syndrome: clinical, genetic, molecular, cellular and ionic aspects (2003) (28)
New Pharmacological Strategies for the Treatment of Atrial Fibrillation (2009) (28)
Atrial fibrillation in inherited cardiac channelopathies: From mechanisms to management. (2016) (28)
Identification of a Novel De Novo Mutation Associated with PRKAG2 Cardiac Syndrome and Early Onset of Heart Failure (2013) (28)
Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene. (2011) (28)
Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest. (2018) (27)
Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria. (2010) (27)
The Enigmatic ECG Manifestation of Brugada Syndrome (1998) (26)
AZD1305 Exerts Atrial Predominant Electrophysiological Actions and Is Effective in Suppressing Atrial Fibrillation and Preventing Its Reinduction in the Dog (2010) (26)
Reflected reentry, delayed conduction, and electrotonic inhibition in segmentally depressed atrial tissues. (1989) (26)
The Contribution of HCN4 to Normal Sinus Node Function in Humans and Animal Models (2010) (25)
Androgens and Male Predominance of the Brugada Syndrome Phenotype (2003) (25)
Genetic predisposition and cellular basis for ischemia-induced ST-segment changes and arrhythmias. (2007) (25)
Molecular Genetics of Arrhythmias and Cardiovascular Conditions Associated with Arrhythmias (2003) (24)
Potent Antiarrhythmic Effects of Chronic Amiodarone in Canine Pulmonary Vein Sleeve Preparations (2009) (24)
Electrophysiological Characteristics of Canine Superior Vena Cava Sleeve Preparations: Effect of Ranolazine (2012) (24)
Tissue-specific effects of acetylcholine in the canine heart. (2013) (24)
Cellular basis for atrial fibrillation in an experimental model of short QT1: implications for a pharmacological approach to therapy. (2010) (24)
Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations. (2012) (23)
Resolving the M-cell debate: why and how. (2011) (23)
LQT5 masquerading as LQT2: a dominant negative effect of KCNE1-D85N rare polymorphism on KCNH2 current. (2011) (22)
Molecular basis for the transmural distribution of the transient outward current (2001) (22)
Molecular and Functional Characterization of Rare CACNA1C Variants in Sudden Unexplained Death in the Young. (2016) (22)
Tpeak-Tend interval as a marker of arrhythmic risk. (2019) (22)
Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome. (2016) (21)
Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis. (2016) (21)
PQ segment depression in patients with short QT syndrome: a novel marker for diagnosing short QT syndrome? (2014) (21)
The antifungal antibiotic clotrimazole potently inhibits L‐type calcium current in guinea‐pig ventricular myocytes (1999) (20)
Identification of Specific Pluripotent Stem Cell Death—Inducing Small Molecules by Chemical Screening (2012) (20)
Electrophysiologic Characteristics and Pharmacologic Response of Human Cardiomyocytes Isolated from a Patient with Hypertrophic Cardiomyopathy (2013) (20)
The Effects of Milrinone on Action Potential Characteristics, Conduction, Automaticity, and Reflected Reentry in Isolated Myocardial Fibers (1985) (20)
Is a narrow and tall QRS complex an ECG marker for sudden death? (2008) (20)
Effects of lidocaine on conduction through depolarized canine false tendons and on a model of reflected reentry. (1982) (20)
Electrical diseases of the heart (2013) (20)
Simulation of the electrocardiographic U wave in heterogeneous myocardium: effect of local junctional resistance (1992) (20)
Pathophysiology : altered regulatory mechanisms in disease (1971) (20)
Early repolarization syndrome: a decade of progress. (2013) (20)
Ventricular fibrillation associated with complete right bundle branch block. (2013) (19)
Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (2022) (19)
The role of local voltage potentials in outflow tract ectopy. (2010) (19)
Cellular Mechanisms Underlying the Brugada Syndrome (2007) (18)
Recent advances in the treatment of Brugada syndrome (2018) (18)
New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias(1). (2001) (18)
Biophysical basis for monophasic action potential (2005) (18)
How Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation? (2008) (18)
The effects of milrinone on conduction, reflection, and automaticity in canine Purkinje fibers. (1984) (18)
Quinidine‐Induced Early Afterdepolarizations and Triggered Activity (1989) (18)
Atrial-selective Prolongation of Refractory Period With AVE0118 is Due Principally to Inhibition of Sodium Channel Activity (2012) (18)
Clinical application of new concepts of parasystole, reflection, and tachycardia. (1983) (17)
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death (2013) (17)
Cellular basis for the normal T wave and the ECG manifestations of the long QT syndrome (1998) (17)
Are M cells present in the ventricular myocardium of the pig? A question of maturity. (1997) (17)
When U Say “U Waves,” What Do U Mean? (2004) (17)
Atria are More Sensitive Than Ventricles to GS-458967-Induced Inhibition of Late Sodium Current (2015) (16)
Chapter 18 – Drug-induced Channelopathies (2004) (16)
Mutations in the Cardiac L-Type Calcium Channel Associated with Inherited Sudden Cardiac Death Syndromes (2010) (16)
SCN5A mutation associated with acute myocardial infarction. (2009) (15)
The Contribution of K+ Currents to Electrical Heterogeneity Across the Canine Ventricular Wall under Normal and Ischemic Conditions (1996) (15)
Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene. (2017) (15)
Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease (2020) (15)
A temporal window of vulnerability for development of atrial fibrillation with advancing heart failure (2014) (15)
Novel therapeutic strategies for the management of ventricular arrhythmias associated with the Brugada syndrome (2015) (15)
Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes (2020) (14)
Mechanisms underlying the antiarrhythmic and arrhythmogenic actions of quinidine in a Purkinje fiber-ischemic gap preparation of reflected reentry. (1986) (14)
Frequency-Dependent Alterations of Conduction in Purkinje Fibers (1983) (14)
Mechanisms of Cardiac Arrhythmia (2008) (14)
J wave syndromes as a cause of malignant cardiac arrhythmias (2018) (14)
Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants. (2021) (14)
A complete right bundle-branch block masking Brugada syndrome. (2012) (13)
Impact of Ancestral Differences and Reassessment of the Classification of Previously Reported Pathogenic Variants in Patients With Brugada Syndrome in the Genomic Era: A SADS-TW BrS Registry (2019) (13)
Developmental changes in expression and biophysics of ion channels in the canine ventricle. (2013) (13)
Selective Pharmacological Modification of Repolarizing Currents: Antiarrhythmic and Proarrhythmic Actions of Agents that Influence Repolarization in the Heart (1995) (13)
Multiple arrhythmic syndromes in a newborn, owing to a novel mutation in SCN5A. (2011) (13)
Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation. (2015) (12)
Short QT Interval: ECG Phenomenon and Clinical Syndrome (2003) (12)
Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute coronary syndromes? (2008) (12)
Antiarrhythmic Effects of Losartan and Enalapril in Canine Pulmonary Vein Sleeve Preparations (2011) (12)
Tpeak-Tend as a predictor of ventricular arrhythmogenesis. (2017) (12)
GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac death (2020) (11)
Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2. (2010) (11)
Role of Repolarization Restitution in the Development of Coarse and Fine Atrial Fibrillation in the Isolated Canine Right Atria (2005) (11)
Pooled Analysis of Risk Stratification of Spontaneous Type 1 Brugada ECG: Focus on the Influence of Gender and EPS (2019) (11)
Empiric Quinidine for Asymptomatic Brugada Syndrome—Preliminary Results of an International Registry (2012) (11)
Electrophysiology and Pharmacology of Ventricular Repolarization (2003) (11)
Multiple serial ECGs aid with the diagnosis and prognosis of Brugada syndrome. (2019) (11)
Electrophysiologic and Antiarrhythmic Effects of AZD1305 in Canine Pulmonary Vein Sleeves (2010) (11)
Extending the Conditions of Application of an Inversion of the Hodgkin–Huxley Gating Model (2013) (11)
Coexistence of atrioventricular accessory pathways and drug‐induced type 1 Brugada pattern (2018) (11)
The Brugada Syndrome. (2005) (10)
Sodium effects on 4-aminopyridine-sensitive transient outward current in canine ventricular cells. (1997) (10)
Reflection as a mechanism of reentrant cardiac arrhythmias. (1987) (10)
Models of Parasystole and Reflection (1983) (10)
Mechanisms of atrial-selective block of sodium channel by ranolazine 2 I . Experimental analysis of the use-dependent block 3 4 (2011) (10)
Cellular and Ionic Mechanisms Underlying Arrhythmogenesis (2003) (10)
How Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation? (2008) (10)
Electrophysiological Characteristics of the M Cell (1997) (9)
Abnormal myocardial expression of SAP97 is associated with arrhythmogenic risk. (2020) (9)
Cardiomyocyte calcium cycling in a naturally occurring German shepherd dog model of inherited ventricular arrhythmia and sudden cardiac death. (2013) (9)
Ajmaline-Induced Slowing of Conduction in the Right Ventricular Outflow Tract Cannot Account for ST Elevation in Patients With Type I Brugada ECG. (2017) (9)
Case scenario: anesthesia-related cardiac arrest in a child with Timothy syndrome. (2012) (9)
Cardiac Arrhythmias: Reentry and Triggered Activity (2001) (9)
Mutations in NaV1.5 Reveal Calcium-Calmodulin Regulation of Sodium Channel (2019) (9)
Epicardial Substrate as a Target for Radiofrequency Ablation in an Experimental Model of Early Repolarization Syndrome (2018) (9)
Disopyramide: although potentially life-threatening in the setting of long QT, could it be life-saving in short QT syndrome? (2006) (9)
Brugada Syndrome: Overview (2007) (8)
The SK Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation via Atrial-selective Inhibition of Sodium Channel Activity. (2020) (8)
Comparison of the Effects of the Transient Outward Potassium Channel Activator NS5806 on Canine Atrial and Ventricular Cardiomyocytes (2010) (8)
A gain-of-function I(K-ATP) mutation and its role in sudden cardiac death associated with J-wave syndromes. (2010) (8)
Inter-Regulation of Kv4.3 and Voltage-Gated Sodium Channels Underlies Predisposition to Cardiac and Neuronal Channelopathies (2020) (8)
Susceptibility to Ventricular Arrhythmias Resulting from Mutations in FKBP1B, PXDNL, and SCN9A Evaluated in hiPSC Cardiomyocytes (2020) (8)
Molecular genetics of arrhythmias and cardiovascular conditions associated with arrhythmias. (2004) (8)
Brugada syndrome: 12 years of progression. (2004) (7)
Drug‐induced Brugada syndrome (2013) (7)
Extracellular Proton Modulation of Peak and Late Sodium Current in the Canine Left Ventricle (2011) (7)
The acquired Brugada syndrome and the paradox of choice. (2009) (7)
Models of parasystole and reentry in isolated Purkinje fibers. (1982) (7)
Genetics and Sinus Node Dysfunction. (2009) (7)
Chronic Exposure to Testosterone Increases Expression of Transient Outward Current in Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cardiomyocytes (CM) (2013) (6)
Ionic and Cellular Basis for Arrhythmogenesis (2011) (6)
Chapter 9. ST Segment Elevation and Sudden Death in the Athlete (2007) (6)
Traditional Chinese Medicine and Vascular Disease (2015) (6)
Contribution of Electrical Heterogeneity of Repolarization to the ECG (2003) (6)
Ranolazine versus amiodarone for prevention of postoperative atrial fibrillation. (2011) (6)
Bases genéticas y moleculares del síndrome de Brugada mediado por canales de sodio (2013) (6)
The J Wave Syndromes and their Role in Sudden Cardiac Death. (2011) (6)
Letters to the Editor (multiple letters) (2003) (6)
Inferolateral J-wave syndromes: A reflection of abnormal repolarization, depolarization, or both? (2019) (6)
Malignant early repolarization: It's the T-wave, stupid…. (2016) (6)
Congenital Short QT Syndrome (2004) (6)
Mechanism of the Preferential Block of the Atrial Sodium Current by Ranolazine (2009) (5)
A Genetic Variant in DPP10 Linked to Inherited J-Wave Syndrome Associated with Sudden Cardiac Death by Augmentation of Kv4.3 Channel Current (2012) (5)
Basic science for the clinical electrophysiologist (2011) (5)
Ionic Basis and Arrhythmia Mechanisms (2001) (5)
Mechanisms Underlying Arrhythmogenesis in Long QT Syndrome (2012) (5)
Abstract 1929: Mutations in the Cardiac L-Type Calcium Channel Associated With Four Sudden Cardiac Death Syndromes (2009) (5)
Differential response of transmural dispersion of repolarization and torsade de pointes to beta-adrenergic agonists and antagonists in three models of the long QT syndrome. (1999) (5)
Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden? (2018) (5)
Clinical Cardiac Electrophysiology Fellowship Teaching Objectives for the New Millennium (2001) (5)
Common variants in SCN10A gene associated with Brugada syndrome. (2021) (4)
Study of the Extent of the Information of Cardiologists from São Paulo City, Brazil, Regarding a Low‐Prevalence Entity: Brugada Syndrome (2008) (4)
Brugada Syndrome : Cellular Mechanisms and Approaches to Therapy (4)
J wave syndromes: What's new?: J wave syndromes. (2021) (4)
Atrial‐selective sodium channel block as a novel strategy for the management of atrial fibrillation (2010) (4)
Diagnostic and genetic aspects of the Brugada and other inherited arrhythmias syndromes. (2007) (4)
Tpeak‐tend interval as a marker of arrhythmic risk in early repolarization syndrome (2019) (4)
The Characteristics of Modulated Parasystole Under Conditions of Constant and Variable Heart Rate: A Mathematical Model (1991) (4)
β-adrenergic stimulation is highly arrhythmogenic following ischemic/reperfusion injury in the isolated canine right atrium (2005) (4)
Expert's opinion☆ (2003) (4)
ECG Phenomena of the Early Ventricular Repolarization: Early Repolarization Syndrome (2003) (4)
Recognition and clinical implications of high prevalence of migraine in patients with Brugada syndrome and drug‐induced type 1 Brugada pattern (2020) (3)
The continuing story: the aetiology of brugada syndrome: functional or structural basis? (letter) (2003) (3)
Abstract 19745: Brugada, Long QT and Cardiac Conduction Disease Overlap Syndrome Associated with the SCN5A-E1784K Mutation: Clinical Phenotype, Genetic Background and Potential Therapy (2012) (3)
Parasystole, reentry, andtachycardia: a canine preparation ofcardiac arrhythmias occurring acrossinexcitable segments oftissue (1983) (3)
Acacetin, a Potent Transient Outward Current Blocker, May Be a Novel Therapeutic for KCND3-Encoded Kv4.3 Gain-of-Function-Associated J-Wave Syndromes (2022) (3)
SUDS and Brugada Syndrome Linked by the Same SCN5A Mutation (2003) (3)
Abstract 1471: Novel Mutation in the KCNQ1 Associated with Brugada Syndrome (2008) (3)
Development of a coronary-perfused interventricular septal preparation as a model for studying the role of the septum in arrhythmogenesis. (2007) (3)
Biophysical Characterization of a Novel KCNJ2 Mutation Associated with Andersen-Tawil Syndrome and CPVT Mimicry (2009) (3)
KCNH2-K897T Polymorphism Increases the Risk of Life-Threatening Arrhythmias Following Acute Myocardial Infarction (2010) (3)
Clinical and Functional Genetic Characterization of the Role of Cardiac Calcium Channel Variants in the Early Repolarization Syndrome (2021) (3)
AZD1305 has Atrial-Predominant Electrophysiologic Actions and is Effective in Suppressing Atrial Fibrillation in the Dog (2009) (3)
The effects of PEG-interleukin-2 and interleukin-2 on essential hypertension and cellular immune function in the spontaneously hypertensive rat. (1993) (3)
Reply to the Editor- Tpeak-Tend is alive and well. (2019) (3)
Electrical diseases of the heart: Second edition volume 1: Basic foundations and primary electrical diseases (2013) (3)
Effect of autonomic influences to induce triggered activity in muscular sleeves extending into the coronary sinus of the canine heart and its suppression by ranolazine (2018) (3)
Abstract 18124: The Role of SCN5A Mutations in J Wave Syndromes (2010) (3)
A carvedilol analogue, VK‐II‐86, prevents hypokalaemia‐induced ventricular arrhythmia through novel multi‐channel effects (2021) (2)
Ranolazine as Antiarrhythmic Agent (2019) (2)
How to prevent sudden death in patients with inherited arrhythmia syndromes or cardiomyopathies (2007) (2)
Intracellular Uptake of Agents That Block the hERG Channel Can Confound Assessment of QT Prolongation and Arrhythmic Risk. (2021) (2)
Brugada Syndrome: Cellular Mechanisms and Approaches to Therapy (2008) (2)
Comprar Electrical Diseases of the Heart · Genetics, Mechanisms, Treatment, Prevention | Wilde, Arthur A. M. | 9781846288531 | Springer (2008) (2)
Theophylline: The forgotten antiarrhythmic drug… now for malignant early repolarization (2018) (2)
Risk stratification [corrected] of Brugada syndrome revisited. (2008) (2)
Clinical approaches to tachyarrhythmias, volume 10: The brugada syndrome (2000) (2)
Basic Science for the Clinical Electrophysiologist Short QT Syndrome : From Bench to Bedside (2010) (2)
A Hotspot in CACNB2B is Associated with J Wave Syndromes Secondary to a Loss of Function of L-Type Calcium Channel Current (2010) (2)
Transcriptional changes associated with advancing stages of heart failure underlie atrial and ventricular arrhythmogenesis (2019) (2)
Ion channels and beating heart: the players and the music (2011) (2)
Abstract 12845: Novel Gain-of-Function N-terminal KCNH2 Mutation Associated with the Short QT Syndrome (2011) (2)
Method for treating atrial fibrillation (2010) (2)
Ionic and Cellular Mechanisms Underlying J Wave Syndromes (2016) (2)
Fractionated Epicardial Electrograms: Implication for Mechanism of the Brugada Pattern. (2021) (2)
Effectiveness of Late INa Versus Peak INa Block in the Setting of Ventricular Fibrillation (2017) (2)
The Role of Spatial Dispersion of Repolarization in Sudden Cardiac Death (2006) (2)
Electrical Diseases of the Heart. Volume 2: Diagnosis and Treatment (2013) (2)
J wave syndromes as a cause of sudden arrhythmic death (2013) (2)
Abstract 15739: Effects of Ranolazine on Long QT3 Syndrome are Mutation Dependent (2011) (1)
BS10 A carvedilol analogue, VKII-86, prevents hypokalaemia-induced ventricular arrhythmia through novel multi-channel effects (2021) (1)
CARDIAC ELECTROPHYSIOLOGY SOCIETY Annual Meeting (2012) (1)
The role of electrical heterogeneity in arrhythmogenesis (2002) (1)
Endocardial Myocytes From the Free Wall of the Canine Left Ventricle (2005) (1)
Brugada Syndrome Genetics (2000) (1)
CLINICAL, GENETIC, MOLECULAR, AND CELLULAR ASPECTS OF THE BRUGADA SYNDROME (2005) (1)
Mechanisms underlying theantiarrhythmic and arrhythmogenic actions ofquinidine inaPurkinje fiber-ischemic gappreparation ofreflected reentry (1986) (1)
Cellular, Molecular, and Pharmacologic Mechanisms Underlying Drug-Induced Cardiac Arrhythmogenesis (2005) (1)
[Genetic and molecular basis for sodium channel-mediated Brugada syndrome]. (2013) (1)
Evaluating the Impact of Sex and Gender in Brugada Syndrome (2019) (1)
ECG Phenomena of the Early Ventricular Repolarization (2003) (1)
The role of spatial dispersion of repolarization and intramural reentry in inherited and acquired sudden cardiac death syndromes (2009) (1)
P5-8: dmLSB, an extract of salvia miltiorrhiza, as a potential therapy for Brugada syndrome (2006) (1)
Call "the Cleaners": How to Treat Drug-Induced Torsades de Pointes. (2015) (1)
Cardiac Arrest: Rare syndromes, commotio cordis, sudden death in athletes (2007) (1)
Reply to the Editor--PQ-segment depression in short QT syndrome patients: a novel marker for diagnosing short QT syndrome? (2014) (1)
Functional identification of hot-spot mutations in cardiac calcium channel genes associated with the J wave syndromes (2023) (1)
Secondary hereditary and acquired cardiac channelopathies and sudden cardiac death (2013) (1)
Novel Mutations in the ATP-Binding Cassette (ABCC8 and ABCC9) Transporter Genes Associated With Inherited J-Wave Syndromes (2011) (1)
GENETIC VARIANTS IN PATIENTS WITH BRUGADA SYNDROME (2016) (1)
Genetics and Sinus Node Dysfunction. (2009) (1)
Advances in basic and translational research in atrial fibrillation (2023) (1)
807-1 Genetic and biophysical basis for sudden death in the short QT syndrome (2004) (1)
Abstract 4413: Accelerated Inactivation of the L-type Calcium due to a Mutation in CACNB2b Underlies the Development of a Brugada ECG Phenotype (2008) (1)
Molecular biology and cellular mechanisms of cardiac arrhythmias and sudden death in infants and young children (2001) (1)
Abstract 15855: A Novel Mutation (D538E) in CACNB2b Associated with Infant Brugada Syndrome (2010) (1)
51 – Genetic, Ionic, and Cellular Mechanisms Underlying the J Wave Syndromes (2018) (1)
The Brugada syndrome. (2002) (1)
NS5806 Activates the Transient Outward Potassium Current in the Canine Ventricle and Provides a New Model of the Brugada Syndrome (2009) (1)
Genetics, Molecular Biology, and Emerging Concepts of Early Repolarization Syndrome (2019) (1)
Pulmonary Vein Sleeves as a Pharmacologic Model for the Study of Atrial Fibrillation. (2010) (1)
Effects of Milrinone on Atrioventricular Conduction in the Canine Heart Under Normal Conditions, During Atrial Flutter and After Ligation and Reperfusion of the Septal Artery (1990) (1)
Faculty Opinions recommendation of Prolonged Tpeak-to-tend interval on the resting ECG is associated with increased risk of sudden cardiac death. (2012) (1)
Mutation in Nav1.5 Associated with Brugada Syndrome - a Mutational Hotspot? (2010) (1)
Arrhythmogenesis Long QT Syndrome (2012) (1)
Short QT Interval (2003) (1)
Brugada-Like Electrocardiographic Pattern (2003) (1)
Ranolazine Causes Atrial-Selective Electrophysiological Effects and Suppresses the Induction of Atrial Fibrillation in a Canine Model of Heart Failure (2012) (1)
Electrical Diseases of the Heart 2nd Ed. (2013) (1)
J Wave Syndromes: From Cell to Bedside (2011) (1)
Developmental Changes in Potassium Channel Expression in the Canine Heart: Implications for Sudden Infant Death Caused by Arrhythmias (2013) (1)
Genome-Wide Association Analysis Identifies 3 Common Variants Predisposing to Brugada Syndrome, a Rare Disease with High Risk of Sudden Cardiac Death (2013) (1)
P6-4: Transmural differences in expression of SCN5A may contribute to the greater sensitivity of ventricular epicardium to electrical depression (2006) (1)
Reply to the Editor (1999) (1)
Abstract 1048: Loss of Function in Calcium Channel Activity Secondary to a Mutation in CACNB2b Modulates the Clinical Manifestation of a Combined Brugada Syndrome-Short QT Phenotype (2006) (1)
P6-9: Ranolazine suppresses atrial fibrillation by exerting a marked use-dependent block of sodium channel current in canine atrium but not ventricle (2006) (1)
Changes of Axial Resistance following Mechanical Strain Prevail Over Stretch-Activated Currents in the Modulation of Conduction Velocity in Cardiac Cell Strands (0)
Comprar Electrical Diseases of the Heart 2nd Ed. | W. Shen | 9781447148807 | Springer (2013) (0)
isolated canine ventricular epicardium. Phase 2 reentry High (Ca2+)o-induced electrical heterogeneity and extrasystolic activity in (2011) (0)
Advances in the Pharmacologic of Atrial Fibrillation (2011) (0)
Abstract session 9: Genetic aspects of cardiac arrhythmias (2009) (0)
P4-1: Trafficking problems associated with a novel mutation (P1008S) in the human SCN5A gene contribute to the development of cardiac conduction defects (2006) (0)
Advances in the Pharmacologic Management of Atrial Fibrillation. (2011) (0)
Use of ranolazine for the manufacture of a medicament for treating arrhythmias (2003) (0)
Extending the Conditions of Application of an Inversion of the Hodgkin–Huxley Gating Model (2013) (0)
Atrial selectivity of ranolazine 1 1 2 3 SUPPLEMENTAL MATERIAL 4 5 6 Mechanisms of atrial-selective block of sodium channel by ranolazine 7 I . Experimental analysis of the use-dependent block 8 9 (2011) (0)
To the Editor: (2003) (0)
Chapter-39 J Wave Syndromes (2017) (0)
relationship to parasystole Characteristics of reflection as a mechanism of reentrant arrhythmias and its (2011) (0)
Abstracts: Genetics in arrhythmiasThe R14Del mutation in phospholamban causes familial dilated cardiomyopathy with attenuated electrocardiographic R amplitudesGenetic variants in NPPA encoding the atrial natriuretic peptide precursor are associated with atrial fibrillationTriple mutation of SCN5A as (2009) (0)
Featured Posters: An overview of cardiac electrophysiology and pacing (2009) (0)
Aging, Heart Disease, and Its Management (2003) (0)
Basic Science for the Clinical Electrophysiologist, An Issue of Cardiac Electrophysiology Clinics (2011) (0)
Computer Simulation of the Cellular Basis for the ECG Configurations of the Brugada Syndrome and Early Repolarization Syndrome (2002) (0)
Regional Variations of the Effects of Acetylcholine in the Canine Heart (2013) (0)
The Brugada numbers - Reply (2003) (0)
Functional Bowel Disorders in Patients with Brugada Syndrome and Drug-Induced Type 1 Brugada Pattern (2020) (0)
The different electrophysiologic effects of E-4031 and BaCl 2 is age-independent. A: (2013) (0)
Abstract 20293: Molecular Genomic and Functional Association of Brugada and Early Repolarization Syndromes with S422L missense mutation in KCNJ8 (2010) (0)
Electrotonic Modulation ofPacemakerActivity Further Biological andMathematical Observations on theBehavior ofModulated Parasystole (1982) (0)
OBSOLETE: Brugada Syndrome (2018) (0)
Faculty Opinions recommendation of Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigs. (2010) (0)
Use of renolazin for the manufacture of a medicament for the treatment of early after depolarizations (EADs) (2003) (0)
Running title: Genome-wide association study in long QT syndrome (2020) (0)
Reply to the Editor–Mechanoelectrical factors in M-cell debate (2011) (0)
Examining the Causes and Consequences of Calcium Overload in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (2013) (0)
Characterization of a Transient Outward K+ Current in Hips-Derived Cardiomyocytes (2013) (0)
J Wave Syndromes: Brugada and Early Repolarization Syndromes (2020) (0)
Mechanisms Underlying Arrhythmogenesis in the J-wave Syndromes (2019) (0)
Contribution of Ventricular Epicardial, Endocardial and M cells to the Inscription of the ECG and the Development of Cardiac Arrhythmias : Cellular Mechanisms for the Long QT and Brugada Syndromes (1999) (0)
Atrial-Selective Drugs for the Management of Atrial Fibrillation (2011) (0)
Mechanisms underlying the increase in refractory period (RP) produced by quinidine (Q) (1977) (0)
A CACNA1C Mutation that Causes a Subset of Timothy Syndrome Phenotypes Correlates (2013) (0)
PART IV: VENTRICULAR EXTRASYSTOLES AND PARASYSTOLE II. MODELS OF PARASYSTOLE AND REFLECTION (1983) (0)
Role of IKr In Maintaining Resting Membrane Potential in Human iPS-Cardiomyocytes (2011) (0)
Novel Timothy Syndrome Mutation Leading to Increase in CACNA 1 C Window Current Short Title : Novel Timothy Syndrome Mutation (2014) (0)
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls (2020) (0)
Differences intheElectrophysiolog ical Response ofCanineVentricular Epicardium and Endocardium toIschemia RoleoftheTransient OutwardCurrent (1993) (0)
J wave syndromes as a cause of sudden cardiac death: From bench to bedside (2016) (0)
Theeffects ofmilrinone on conduction, reflection, andautomaticity incanine Purkinje fibers (1984) (0)
Electrocardiographic Curiosities Expert's Opinion (2003) (0)
Mechanisms underlying rate dependent changes of refractoriness in segmentally depressed purkinje fibers (1985) (0)
Modulated para systole reflection and tachy cardia a canine model of electrotonically mediated cardiac dys rhythmias (1982) (0)
Preface: Basic Science for the Clinical Electrophysiologist (2011) (0)
Aha Conference Proceedings American Heart Association Atrial Fibrillation Research Summit a Conference Report from the American Heart Association Mechanisms of Af: Basic and Translational Science and Genetics (2011) (0)
effect of acetylcholine in ventricular myocardium subendocardium and subepicardium to acetylcholine and isoproterenol. A direct Differences in the electrophysiological response of canine ventricular (2011) (0)
Risk Strataification of Brugada Syndrome Revisited (2008) (0)
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome (2021) (0)
Abstract 3394: Gain of Function in IKs Secondary to a Mutation in KCNE5 as a Cause of Atrial Fibrillation (2006) (0)
52 – Genetics and Cellular Mechanisms of the J Wave Syndromes (2014) (0)
A method for the treatment of atrial fibrillation (2010) (0)
Post-Pacing Abnormal Repolarization in Catecholaminergic Polymorphic Ventricular Tachycardia Associated with a Mutation in the Cardiac Ryanodine Receptor Gene (RyR2) (2011) (0)
Rhythm Society and the European Heart Rhythm Association Brugada Syndrome: Report of the Second Consensus Conference : Endorsed by the Heart (2013) (0)
Case Scenario: Anesthesia-Related Cardiac Arrest in a Child With Timothy Syndrome (2013) (0)
Increased susceptibility to ventricular arrhythmia at low-normal and moderately-low levels of extracellular potassium in Catecholaminergic Polymorphic Ventricular Tachycardia. (2022) (0)
Abstract 17091: Cellular Mechanisms Underlying the Effects of Antidepressants to Unmask the Brugada Syndrome (2010) (0)
From the American Heart Association American Heart Association Atrial Fibrillation Research Summit: A Conference Report (2013) (0)
1130-208 Diagnostic value of the Ajmaline test based on the gene analysis in concealed brugada syndrome (2004) (0)
Electrocardiographic differences between Timothy syndrome and LQT3 children (2005) (0)
Comprar Electrical Diseases of the Heart 2nd Ed. | I. Gussak | 9781447149774 | Springer (2013) (0)
current in the canine left ventricle + Extracellular proton depression of peak and late Na (2011) (0)
Dual Variations in SCN5A and CACNB2b Underlie Cardiac Conduction Disease without Brugada Syndrome (2009) (0)
Biophysical and Molecular Analysis of the Sodium Current in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (2015) (0)
Frequency of Irritable Bowel Syndrome in Patients with Brugada Syndrome and Drug-Induced Type 1 Brugada Pattern. (2021) (0)
Wave Syndromes . From Cell to Bedside (2011) (0)
A Decade of Progress (2002) (0)
otential Proarrhythmic Effects of Biventricular Pacing (2016) (0)
299 The prevalence and role of SCN10A variants in Han Chinese patients with Brugada syndrome: the SADS-TW BrS registry (2020) (0)
05 Terfenadine-induced ST segment elevation and the Brugada syndrome (2002) (0)
Physiological Effects of Transient Outward K+ Current Activation during Heart Failure in the Canine Left Ventricle (2012) (0)
Identification of Specific Pluripotent Stem Cell Death—Inducing Small Molecules by Chemical Screening (2011) (0)
Mechanisms Underlying the Development of Cardiac Arrhythmias (2020) (0)
Descripción de la utilización de cuñas ventriculares aisladas de corazón canino en el laboratorio de electrofisiología experimental (2012) (0)
Gordon K. Moe, M.D., Ph.D.: Twenty-five years as Director of Research of the Masonic Medical Research Laboratory (1990) (0)
Cellular Basis for T Wave : Role of M Cells (2001) (0)
mathematical observations on the behavior of modulated parasystole Electrotonic metabolism of pacemaker activity. Further biological and (2011) (0)
THE PHENOTYPIC SPECTRUM OF MOST FREQUENT MUTATION RESPONSIBLE FOR THE SHORT QT SYNDROME (2016) (0)
Abstract 1049: A Single Amino Acid Deletion in KCNQ1 Associated with a Potent Dominant Negative Effect as a Cause of Long QT Syndrome (2006) (0)
AS AMERICANS, WE SHOULD GET THIS RIGHT. AUTHORS' REPLY (1999) (0)
Abstract 14459: Genome-Wide Association Analysis Identifies 3 Common Variants Predisposing to Brugada Syndrome, a Rare Disease With High Risk of Sudden Cardiac Death (2013) (0)
Ryanodine receptor inhibition prevents ventricular arrhythmia in a murine model of hypokalaemia (2020) (0)
Reply to Letter to the Editor Biophysical basis for monophasic action potential (2005) (0)
Author's response to letter to the editor from Perez and Froelicher. (2013) (0)
Electrical Heterogeneity as the Basis for Inscription of the ECG and the Long QT Syndrome (2000) (0)
A Mutation Hotspot in KCNH2 associated with Short QT Syndrome, SCD and SIDS (2011) (0)
LOCAL VOLTAGE POTENTIALS ARE PREREQUISITES FOR OUTFLOW TRACT ECTOPY (2010) (0)
Should theophylline be added to the J wave syndrome therapeutic armamentarium? (2018) (0)
Mechanisms underlying the antiarrhythmic and arrhythmogenic actions of quinidine on reentrant arrhythmias (1985) (0)
Mechanisms of Action of Antiarrhythmic Drugs in Atrial Fibrillation (2013) (0)
The use of ranolazine for the manufacture of a medicament for the treatment of arrhythmias (2003) (0)
Effects of SK Channel Blockers on Atrial Myocytes Suggest SK Channel Heterogeneity (0)
Editorial Congenital Short QT Syndrome (2004) (0)
Short QT Syndrome: Clinical Presentation, Molecular, Genetic, Cellular, and Ionic Basis (2011) (0)
Electrocardiographic variables associated with underlying Brugada syndrome or drug‐induced Type 1 Brugada pattern in patients with slow/fast atrioventricular nodal reentrant tachycardia (2022) (0)
How Do We Measure Repolarization Inside the Heart (2003) (0)
Differential Effects of the Transient Outward K+ Current Activator NS5806 in the Canine Left Ventricle (2009) (0)
PM398 Mechanisms Underlying High Temperature-Induced Arrhythmogenesis In An Experimental Model Of Brugada Syndrome (2014) (0)
subepicardium of the canine ventricle. The M cell A subpopulation of cells with unique electrophysiological properties in the deep (2011) (0)
Novel Pharmacological Targets for the Management of Atrial Fibrillation (2009) (0)
Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia-mediated acquired Brugada syndrome (2005) (0)
Atrial-selectivesodiumchannel blockforthetreatmentofatrial fibrillation (2009) (0)
Short QT Syndrome (2020) (0)
Human Induced Pluripotent Stem Cells: Role in Patient-Specific Drug Discovery (2012) (0)
Comprar Basic Science for the Clinical Electrophysiologist, An Issue of Cardiac Electrophysiology Clinics | Charles Antzelevitch | 9781455704231 | Saunders (2011) (0)
19 The Brugada Syndrome (2003) (0)
Comprar J Wave Syndromes. Brugada And Early Repolarization Syndromes | Charles Antzelevitch | 9783319315768 | Springer (2016) (0)
Clinical Reviews: Drugs and Devices (2018) (0)
Abstract 19725: Prevalence and Clinical Phenotype of Sodium and Calcium Channel Mutations in Brugada Syndrome (2010) (0)
The Role of Conduction Delay for the Arrhythmogenesis in Brugada Syndrome : Three Dimensional Computer Simulation Study (2003) (0)
Reply to the Editor (2000) (0)
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (2022) (0)
Advances in the Pharmacological Treatment of Atrial Fibrillation. (2010) (0)
Mechanoelectrical factors in M-cell debate (2011) (0)
Cellular Basis for QT Prolongation, T wave Inversion and Cardiac Arrhythmias Induced by Intra-Coronary Injection of Angiographic Contrast Media (2002) (0)
Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (2022) (0)
Cellular basis for the electrocardiographic and arrhythmic manifestation of Timothy Syndrome (2005) (0)

This paper list is powered by the following services:

Other Resources About Charles Antzelevitch

What Schools Are Affiliated With Charles Antzelevitch?

Charles Antzelevitch is affiliated with the following schools:

Charles Antzelevitch's Academic­Influence.com Rankings

Charles Antzelevitch's Degrees

Why Is Charles Antzelevitch Influential?

Charles Antzelevitch's Published Works

Published Works

Other Resources About Charles Antzelevitch

What Schools Are Affiliated With Charles Antzelevitch?

Image Attributions

Charles Antzelevitch's AcademicInfluence.com Rankings